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Sustainable schistosomiasis control cannot be based on large-scale vertical treatment strategies in most
endemic countries, yet little is known about the costs and effectiveness of more affordable options. This
paper presents calculations of the cost-effectiveness of two forms of chemotherapy targeted at school-
children and compares them with chemotherapy integrated into the routine activities of the primary health
care system. The focus is on Schistosoma haematobium. Economic and epidemiological data are taken
from the Kilombero District of Tanzania. The paper also develops a framework for possible use by pro-
gramme managers to evaluate similar options in different epidemiological settings. The results suggest
that all three options are more affordable and sustainable than the vertical strategies for which cost data
are available in the literature. Passive testing and treatment through primary health facilities proved the
most effective and cost-effective option given the screening and compliance rates observed in the
Kilombero District.
Introduction
It is now generally accepted that most of the
endemic countries in sub-Saharan Africa are
unable to sustain large-scale vertical
schistosomiasis control programmes from their
own resources (Evans 1992; Guyatt and Evans
1992). The search for more affordable yet effec-
tive options has focused on two forms of
chemotherapy aimed at morbidity reduction.
The first involves targeting treatment at high-risk
groups such as school-children; the second in-
volves integrating chemotherapy into the day to
day activities of the primary health care system
(Gryseels 1989; Tanner 1989). However, virtually
no data are available on the costs and effec-
tiveness of these options. The first purpose of
this paper, then, is to estimate the likely costs
and coverage under three possible variations of
these strategies.
The second purpose is to develop a methodology
which may be generally applicable to such plan-
ning exercises. One problem with the existing
studies on the costs of chemotherapy pro-
grammes in schistosomiasis control (for ex-
ample, Korte et al. 1986; Brinkmann et al. 1988;
Jobin 1989; Rohde 1989) is that the methodo-
logies used have been unclear - details of the
items included as costs and the way they were
measured are rarely provided, for example. A
consistent format for estimating costs is required
to allow consistent comparisons of the different
options and an evaluation of how variations in
economic and epidemiological data affect the
relative attractiveness of the options (Reynolds
and Gaspari 1985; Bundy and Guyatt 1992). A
step-by-step cost analysis illustrating how
economic and epidemiological data can be used
to evaluate alternative control options at the
district level is, therefore, presented. The
methodology would also be appropriate to
smaller administrative units of an endemic area.
Two of the options considered are targeted at
school-children, believed to be a high-risk group
which is relatively accessible to chemotherapy
programmes. The third provides screening and
treatment at primary health care facilities,
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available to anyone who requests it. Clearly the
target population differs in the third option,
reflecting the sort of choices planners face in
choosing between targeted control and delivery
through the primary health care system. The
analysis focuses on Schistosoma haematobium
and is based on actual economic and epidemi-
ological data collected from surveys and con-
trol interventions in the Kilombero District of
Tanzania.
(Lengeler et al. 1991b). The second study is part
of the ongoing Communicable Disease Control
project based at the Ifakara Centre with close
collaboration with the District Medical Officer
and the District Education Officer. As part of
this project, 4 dispensaries serving communities
of high prevalence were provided with the
trained personnel, equipment and drugs
necessary for the diagnosis and treatment of
schistosomiasis as part of their routine activities.
Methods
Study area
The Kilombero District is in the Morogoro
Region, south-eastern Tanzania, and has been
described in detail elsewhere (Tanner et al. 1987;
Tanner et al. 1991). The population according to
the 1988 national census was 187 000, and 22 108
children were enrolled in the 77 primary schools
(Lengeler et al. 1991a). The District contained
one District Hospital at Ifakara, two Rural
Health Centres, 13 Government and 7 Mission
dispensaries. Most of the dispensaries are poorly
equipped and have no electricity, materials or
drugs required for schistosomiasis testing and
treatment. In particular, most dispensaries do
not have a microscope in working order (Gilson
1992).
Urinary schistosomiasis is endemic in most
villages, though infection prevalence varies
widely between sites. The average infection
prevalence observed from surveys of school-
children was 21% (median: 12.5%), but reached
70-80% in some schools (Lengeler et al. 1991a).
The high and widespread endemicity of
schistosomiasis in this area has stimulated a
number of research and control projects (Tanner
et al. 1991), mostly initiated by the Ifakara
Centre (former Swiss Tropical Institute Field
Laboratory) and the Swiss Tropical Institute in
Basel. Two in particular provide data for the cur-
rent analysis. The first was undertaken between
1986 and 1987 in Kilombero, and in 1988 in the
neighbouring Kilosa District. As part of this
study, most schools in the Kilombero District
were surveyed for schistosomiasis by a mobile
team (Lengeler et al. 1991a) and the use of
teachers in reagent strip testing of school-
children was investigated in Kilosa District
The epidemiological and economic data from
these studies, and some additional data obtained
from the District Medical Officer, District
Education Office and Accounting Department at
the Ifakara Centre, have been used as baseline
data for the analysis of the comparative costs
and coverage achieved by the three distribution
strategies: 1) annual mass treatment of school-
children by a mobile team, 2) annual reagent
strip testing of school-children by teachers and
referral to the dispensary for treatment, and 3)
passive testing and treatment at the dispensary
level.
Description of control alternatives
Mass treatment by a mobile team (MMT)
This option involves the annual mass treatment
of all primary school-children by a mobile team
comprising one driver, one fieldworker and one
Rural Medical Aid. All 77 schools are visited and
all children present are treated with a single oral
dose of praziquantel (40 mg/kg). Transport is
provided by a rented vehicle. The mobile team
(excluding the driver) undergo annual training at
the Ifakara Centre under the guidance of a
Medical Assistant. In some situations it would be
more efficient to screen schools before treating
only the positives; the extra costs of screening
would be more than offset by reduced costs of
treatment. The level of prevalence at which it is
better to screen before treatment has been
discussed elsewhere (Prescott 1987), and for the
purposes of this exercise it is assumed that no
prior screening is undertaken. It might also be
preferable in some circumstances to treat only
schools known or believed to have high
prevalences of infection. The implications of
choosing this option will be considered in a
subsequent paper, but here the implications of
mass treating all schools in a given geographical
area will be considered.
Affordable delivery strategies 387
Reagent strip testing by school teachers (RST)
In this option teachers annually screen children
using Sangur reagent strips (Boehringer, Mann-
heim, FRG) and refer all positives to the nearest
dispensary for treatment. One teacher per school
attends a workshop for training in reagent strip
testing, where they also receive health education
and materials required for screening their school.
The workshop team consists of one expert, two
fieldworkers and one driver. Transport is pro-
vided by a rented vehicle. Training the teachers
involves the use of 10 reagent strips per teacher.
The programme is supervised by a Medical Assis-
tant making annual visits to all schools as part of
a routine supervisory visit to the local health
facilities. The visits aim at motivating teachers
and preparing them for the next round of screen-
ing and treatment.
Passive testing and treatment at the dispensary
(PTT)
Control is provided by passive case detecting
using urine sedimentation and subsequent treat-
ment of positives with a single oral dose of prazi-
quantel (40 mg/kg). This requires the provision
of trained staff and equipment for screening and
treatment at all dispensaries (including the two
Health Centres). All dispensaries are provided
with a microscope and one person from each
dispensary is trained to perform the diagnostic
technique. Training involves a one-day
workshop at facility level in each division. Each
workshop team consists of one expert, two
Medical Assistants, one District Health Officer
and one driver. Transport for the workshop team
is provided by a rented vehicle. All materials
utilized in training form part of the bulk package
given to each dispensary. This basic diagnostic
package consists of 1 bucket, 20 urine con-
tainers, 20 urine sedimentation containers, 100
slides, 1000 coverslips, 4 litres of disinfectant and
10 pasteur pipettes and teats. Supervision is
undertaken by a Medical Assistant who visits
each dispensary twice a year, their transport
being provided by a rented vehicle and a driver.
Data sources
Salaries and per diems of teachers were obtained
from the District Education Office; those for
dispensary workers (Rural Medical Aids,
Medical Assistants and laboratory technicians)
and the District Health Officer were obtained
from the District Medical Office. The Accoun-
ting Office at the Ifakara Centre provided details
of salaries and per diems for fieldworkers,
drivers and experts (based on Tanzanian para-
statal salary scales), as well as information on
vehicle rental and running costs. Microscope
purchase prices (including freight) were provided
by Tropical Health Technology (Cambridgeshire,
England). The Communicable Disease Control
project (Ifakara Centre) provided costs for all
dispensary screening materials, while the costs of
screening materials for reagent strip testing were
taken from Lengeler et al. (1991b).
Productivity of personnel in performing tasks at
the dispensaries was based on experience in the
Communicable Disease Control project and
observation at the dispensaries. An estimate of
the cost of praziquantel was obtained from
UNICEF (UNICEF Supply Division, Freeport,
DK-2100 Copenhagen) and includes freight
costs. Demographic data were based on the 1988
census and attendance rates at school were
provided by the District Education Office. The
prevalence of infection at each school was taken
from Lengeler (1989).
Unit cost menu
In this analysis, the health care provider's
perspective is taken by estimating the extra finan-
cial costs inherent in each option. The full costs
of hiring new staff, for example, are included in
this financial analysis. The time of existing staff
who are diverted to a control option is recorded
separately and multiplied by the Official wage to
provide an idea of the opportunity cost of diver-
ting staff. Although these staff are already being
paid, and their involvement in the programme
imposes no extra financial costs on the provider,
the need to divert the time of skilled staff is likely
to influence the assessment from the provider's
viewpoint. Accordingly, these opportunity costs
are added to the financial costs and the sum is
called the 'economic costs', recognizing that
some of the prices used in the calculations may
not reflect true economic or shadow prices.
The itemized cost data for each strategy is given
in Tables la-c. The cost menu is designed to be
simple enough for field use by programme
managers, whilst flexible enough to incorporate
some of the more complex issues of costing.
Each item is categorized under the headings Per-
sonnel, Vehicle, Consumables and Capital items.
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The units for each item are identified and the
unit costs are further classified under the activity
classes of Supervision, Training, Screening and
Treatment. For the purposes of this analysis, all
costs are reported in 1991 US dollars. Personnel
and transport costs are initially paid in local cur-
rency (Tsh) and converted to US$ using the of-
ficial exchange rate of 250 Tsh per US$ (average
1991 exchange rate from the Bank of Tanzania).
For budgeting purposes it can be important to
consider domestic and foreign exchange costs
separately. The cost menus presented here can be
easily adapted for this.
The only financial costs for salaries are for the
Ifakara Centre staff (i.e. driver, fieldworkers
and expert). In addition to their salaries, per
diems are paid to all staff employed by the pro-
Table 1. Unit cost menu for (a) mass treatment by the mobile team (MMT), (b) reagent strip testing by
teachers (RST) and (c) passive testing and treatment at the dispensary (PTT)
(a)
Category
Personnel
Vehicle
Consumables
(b)
Item
Driver's salary
Driver's per diem
Fieldworker's salary
Fieldworker's per diem
RMA's salary
RMA's per diem
MA's salary
MA's per diem
Running costs
Rental
Drug
Units
per day
per day
per day
per day
per day
per day
per day
per day
per km
per km
per child
Unit cost
Training
2
12
1.2
10.4
1.6
10.4
0.25
0.48
(US$)
Treatment
2
12
2
12
1.2
10.4
0.25
0.48
0.66
Category Item Units Unit cost (US$)
Supervision Training Screening Treatment
Personnel
Vehicle
Consumables
Driver's salary
Driver's per diem
Expert's salary
Expert's per diem
Fieldworker's salary
Fieldworker's per diem
Teacher's salary
Teacher's per diem
RMA's salary
MA's salary
MA's per diem
Running costs
Rental
Reagent strips
Urine pots
Record card
Drug
per day
per day
per day
per day
per day
per day
per day
per day
per day
per day
per day
per km
per km
per person
per child
per child
per child
2
12
1.6
10.4
0.25
0.48
2
12
4
18
2
12
1.8
10.4
0.25
0.48
2
1.8
0.2
0.042
1.2
0.01
0.66
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(c)
Category
Personnel
Vehicle
Consumables
Capital
items*
Item
Driver's salary
Driver's per diem
Expert's salary
Expert's per diem
Health Officer's salary
Health Officer's per diem
MA's salary
MA's per diem
Lab. technician's salary
Lab. technician's per diem
RMA's salary
Running costs
Rental
Slides
Coverslips
Disinfectant
Pasteur pipettes and teats
Drug
Microscope
Bucket
Urine containers
Urine sedimentation
containers
Units
per day
per day
per day
per day
per day
per day
per day
per day
per day
per day
per day
per km
per km
per dispensary
per dispensary
per dispensary
per dispensary
per dispensary
per dispensary
per dispensary
per dispensary
per dispensary
Supervision
2
12
1.6
10.4
0.25
0.48
Unit
Training
2
12
4
18
6
10.4
1.6
10.4
0.8
10.4
0.25
0.48
cost (US$)
Screening
0.8
1.2
6.08
17.48
32
7.98
1486.35
4
3.04
7.6
Treatment
1.2
0.99
• indicates purchase price; these are annualized in the cost analysis
RMA = Rural Medical Aid, MA = Medical Assistant.
ject for their time in the field, and to all existing
personnel spending time away from home for
training workshops, etc.
The only capital expenditures included occur at
the dispensary level. The annualized cost of a
microscope is calculated using a life expectancy
of 10 years and an interest rate of 10%. The
reusable items utilized for screening are assumed
to have a life expectancy of 3 years. Since the
microscope will not only be used for
schistosomiasis control, this represents the worst
possible case for the cost of the passive detection
and treatment (PTT) option. No new buildings
would be required for any of the control options;
a small part of existing space will be diverted oc-
casionally, but this is not likely to influence the
provider's decision as it does not prevent other
activities being undertaken. The initial training
workshops for dispensary workers and teachers
are considered to be capital outlays with a life ex-
pectancy of 3 years, and thus are annualized over
this time period using an interest rate of 10%.
Praziquantel was available at US$ 282 per 1000
tablets of 600 mg. Including airfreight costs (US$
175 for 4000 tablets (WHO)), one tablet costs
US$ 0.33. For treating children, it is assumed
that 2 tablets are required per child at a cost per
dose of US$ 0.66 for the mobile team and
reagent strip testing and treatment options. In
the dispensary option both adults and children
are treated and thus it is assumed that on average
3 tablets per dose are required, giving a cost per
dose of US$ 0.99. In many situations, patients
would be required to meet some of the costs, and
although this could be incorporated in the
menus, this analysis assumes all costs are met by
the programme. The price of praziquantel seems
to vary not only by supplier, but also by
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customer, and over time for any supplier. The
impact of such variations is considered in the
sensitivity analysis.
Economic parameters
Mass treatment by a mobile team (MMT)
Field experience suggests that the mobile team
can cover 2 schools per day. Allowing for travel
time, the District could be covered in 45 working
days. This would involve travelling 1000 km to
reach all the schools in the District. Annual train-
ing would involve 2 days at the Ifakara Centre.
Reagent strip testing by school teachers (RST)
Each workshop would take one day and 4
workshops would be required to cover the whole
district (one each in Ifakara, Mlimba, Mngeta
and Mang'ula). Including travel time, the
workshop team would be required for 7 days,
and would travel 500 km to reach all workshop
destinations. Screening by teachers should only
take place between 10am and 2pm due to the cir-
cadian variation of haematuria (Lengeler et al.
1991c), and one teacher could screen 100 children
during this time period. This time taken
represents approximately half of a normal work-
ing day. In a full working day the Rural Medical
Aid at the dispensary could treat 120 children
referred to the dispensary. Supervisory visits by
the Medical Assistant are assumed to take one
sixth of the time of a regular visit to the
neighbouring health facilities.
Passive testing and treatment at the dispensary
(PTT)
As in the RST option, each training workshop
would take one day, with 4 workshops for the
whole district. Again, the workshop team would
be required for 7 days and would travel 500 km.
A patient attending the dispensary would firstly
be received by the Rural Medical Aid for a con-
sultation taking approximately 5 minutes. A
urine sample would be taken and the diagnostic
test would take approximately 10 minutes. For a
positive test the patient would receive a prescrip-
tion and treatment from the Rural Medical Aid
taking approximately 4 minutes. The Medical
Assistant visits all health facilities twice a year,
spending one day at each dispensary per visit.
Travel to all dispensaries for one round of visits
encompasses 1000 km. Supervision for schisto-
somiasis control is assumed to take one third of
the time of a regular supervisory visit.
Epidemiological and demographic parameters
Mass treatment by a mobile team (MMT)
For each of the 77 schools, the number of
children registered and the prevalence of infec-
tion is known. Using the 82% attendance rate of
registered students provided by the District
Education Office, a total of 18 094 children
would be present on any given day and 3495 of
them would be infected. Past experience in the
area suggests it is reasonable to assume that
100% comply with treatment by the mobile
team, although lower levels of compliance could
be built into the calculations.
Reagent strip testing by school teachers (RST)
If 100% of children complied with the reagent
strip testing, 18 094 would be screened. Given
that the test is 75.4% sensitive and 88.7%
specific (Lengeler 1989), and assuming a com-
pliance for treatment of 90%, 3856 children
would be treated under this option, of whom
2372 would be infected.
Passive testing and treatment at the dispensary
(PTT)
Data from the Communicable Disease Control
project indicate that approximately 11 % of the
total population are screened in one year through
the routine activities of dispensaries. The
denominator used in this calculation was the
total population including school-children.
However, the numerator did not include school-
children who were treated separately in the pro-
ject. If they are assumed to present at dispen-
saries in the same proportion as the rest of the
population, approximately 16% of the total
population (29 920 people) would be screened at
the dispensaries in any given year. Data from the
Communicable Disease Control project also
show that 40% of those screened for urinary
schistosomiasis at dispensaries were positive and
60% negative, suggesting that 11 968 of the
29 920 persons screened would be infected. If
between 10-15% of the overall population is in-
fected (a realistic estimate based on the known
21% of school-children who are infected), then
between 43-64% of the infected population
would be screened at the dispensaries each year.
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It is important to note that the target group for
PTT is the entire population, whereas RST and
MMT target only school-children. The rationale
for this difference in target group is that both
RST and MMT are only suitable for targeting at
children, because firstly, the specificity of RST in
adults is low and secondly, a test and treat cam-
paign using MMT which includes the adult
population involves operational problems in
reaching them. PTT is an option available to the
entire population and it would be unethical to
confine this service only to the children. In this
present example, RST treats 2372 infected
children, MMT treats 3495 infected children and
PTT treats 11 968 infected children and adults.
The relatively low number of infected children
treated through the school-based approaches
(RST and MMT) is due largely to the low school
registration rates in the area (approximately
50%).
Results
Details of the unit prices used in the cost calcula-
tions are provided in Table 1. The total cost of
each alternative for one year, the total number of
infected people treated, and the cost per infected
person treated under the three options are found
in Table 2. Total financial and economic costs
are both presented, the latter defined as the
financial costs plus the opportunity costs of
utilizing existing personnel. Both the financial
and economic costs produce similar qualitative
results. RST is the least costly and PTT is the
most expensive. The opposite ranking occurs in
terms of effectiveness, with PTT resulting in the
most infected people being treated, and RST in
the least. The implications of these results for
control are complex.
Take the choice between MMT and RST, both
delivered through schools. The more efficient
option in terms of the cost per infected person
treated would be RST, which would also be ap-
proximately $7000 cheaper than MMT on a
district wide basis. However, 1123 fewer infected
children would be treated using RST. The con-
trol programme must decide whether it is worth
spending the extra $7000 to treat an extra 1123
children. This is a value judgement, and other
possible uses of the $7000 would have to be taken
into account at least implicitly.
The PTT option is even more expensive, but
results in a very large increase in effectiveness,
with many more infected people treated.
However, this option is likely to be divisible in
the sense that it could be applied to only part of
the District if necessary. For example, with
reference to Table 2, assume that the control pro-
gramme has decided it is worth spending the
extra funds on MMT, in which case 3495 children
could be treated for $15 663. The same total ex-
penditure could result in 8798 infected people
being treated through dispensaries (PTT) simply
by restricting the availability of testing and treat-
ment to 73.5% (15 663/21 307) of the district. A
similar argument applies to the comparison be-
tween RST and PTT: for the $8803 required by
RST, 4945 infected people could be treated by
restricting the availability of PTT to 41.3<Vo
(8803/21 307) of the district. Reducing the scope
of PTT therefore allows more infected people to
be treated than either MMT or RST, at no extra
cost. As long as it is divisible, PTT is the pre-
ferred option.
It is possible that decision-makers would not be
willing to divide the PTT option in this way.
Table 2. Comparison of the cost and cost-effectiveness of the three control options in the first year
Total cost (USS)
Number of infected
persons treated
Cost per infected
person treated (USS)
Financial
Economic
Financial
Economic
Mass treatment by a
mobile team (MMT)
15663
15723
3495
4.48
4.50
Reagent strip testing
by teachers (RST)
8803
9072
2372
3.71
3.82
Passive testing and treatment
at dispensaries (PTT)
21307
22430
11968
1.78
1.87
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Table 3. The percentage distribution of costs by input category and activity
Input
categories
Activity
categories
Personnel (opp. salaries)
Personnel (fin. salaries)
Personnel (fin. allow.)
Vehicle
Supplies (excl. drugs)
Drug
Supervision
Training
Screening
Treatment
Mass treatment by a
mobile team (MMT)
0.4%
1.2%
10.3%
4.6%
n.a.
83.5%
n.a.
0.5%
n.a.
99.5%
Reagent strip testing
by teachers (RST)
3.0%
0.5%
7.0%
4.3%
54.3%
30.9%
4.8%
8.5%
54.9%
31.8%
Passive testing and treatment
at dispensaries (PTT)
5.0%
0.2%
2.7%
2.8%
31.2%
58.1 %
3.9%
2.0%
35.4%
58.7%
Notes: fin. •= financial, opp. = opportunity, n.a. = not applicable
However, as long as the total number of infected
people treated is accepted as a useful indicator of
effectiveness, PTT is potentially the most cost-
effective option. And clearly it would also be
possible for the programme to extend the option
to the entire District if the extra expenditure was
judged worthwhile.
The percentage distribution of costs by input
category and by type of activity is found in Table
3. This information is useful for managers
seeking to introduce economies into the system,
and is a valuable part of the cost menu. It is also
useful for considering which items should be
included in a sensitivity analysis, illustrated with
respect to drug costs.
Praziquantel accounts for the largest proportion
of costs for both MMT (83.5%) and PTT
(58.1%), and is second only to supplies such as
reagent strips in RST. The price, however, has
been falling in recent years and Figure 1 shows
that further reductions would not only reduce the
total Financial costs of each option, but could
alter the relative attractiveness of MMT and
RST. If drug costs were reduced by more than
67%, MMT would become more affordable than
RST, and would, with its greater effectiveness,
be a more attractive option. Figure 2 illustrates
this by considering the effect of falling drug costs
on the cost per infected person treated under
each approach. A reduction in drug costs of
more than 30% would make MMT more
efficient than RST.
However, these figures also show that PTT
remains the most cost-effective option even if
drug costs are reduced by 100%, i.e. if
praziquantel were provided free. Although these
figures are based on changes in financial costs,
the conclusions do not alter when economic costs
are considered. Accordingly, for any realistic
price of praziquantel, PTT remains the option of
choice.
Discussion
The total costs of an intervention indicate
affordability. Tanzania's annual governmental
health expenditure was US$ 27 million in 1991/2,
and based on an approximate population of 22
million, annual per capita expenditure was US$
1.20. Although not directly comparable, the
financial cost per capita of MMT, RST and PTT
of US$ 0.08, 0.05 and 0.11 in turn, are well
below actual per capita government health
expenditures. Certainly, the estimates here of
cost per capita and cost per infected person
treated (see Table 2) are much lower than
previous estimates of schistosomiasis control
options (Evans 1992; Guyatt and Evans 1992),
and being more affordable, are more likely to be
sustainable.
The strong conclusion that PTT is both affor-
dable and the most cost-effective option is to
some extent dependent on the outcome measure
used to assess effectiveness. In this analysis the
number of infected persons treated, adults plus
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Figure 1. The effect of reducing drug costs on the total financial cost of each control
option
The total economic costs produce similar patterns, though the threshold drug reduc-
tion required to change the ranking of RST and MMT is lower (0.65).
Cost per infected person treated (in US$)
0.2 0.4 0.6 0.8 1
Proportion reduction in drug costs
Figure 2. The effect of reducing drug costs on the cost per Infected person treated
The costs in this figure represent financial costs only. The total economic costs pro-
duce similar patterns, though the threshold drug reduction required to change the
ranking of RST and MMT is lower (0.27).
children, was used as the indicator of effec-
tiveness. If, however, the reduction in morbidity
resulting from treating one child were greater
than that for treating one adult, the results
overstate the relative attractiveness of PTT com-
pared to RST and MMT. Nevertheless, at the ex-
treme, when effectiveness is measured only as the
number of infected children treated, PTT re-
mains the most cost-effective option.
Clearly, adults suffer chronic morbidity, but the
impact of treatment on this is not clear, nor is the
relative benefit of treating adults compared to
children. A more appropriate outcome measure
would be the reduction in morbidity itself,
measured over more than one time period. This
would require a dynamic approach to the
calculations, perhaps following the approach
taken with the intestinal nematodes (Guyatt et al.
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1993; Medley et al. 1993). A dynamic model
might also expose the fact that while PTT
results in treatment throughout the year, the
school-based approaches result in relatively
simultaneous treatment across communities,
perhaps with different effects on the dynamics of
transmission. We are currently working on the
extension of the nematode models to schistoso-
miasis, but to date no direct indicator of mor-
bidity which can be used in cost-effectiveness
studies of schistosomiasis control options is
available, even for static models (Guyatt and
Evans 1992).
The percentage distribution of input costs is
useful to indicate which items constitute the
highest expense, and thus which areas have a
large potential for savings. In this analysis, drug
costs constituted a large proportion of the total
costs for MMT and PTT, but less so for RST.
This has important implications as a continued
fall in the price of praziquantel can influence the
ranking of alternatives as well as their afford-
ability. It is also possible that the unit cost of
reagent strips may be reduced in the near future,
perhaps by as much as three-quarters. This
would further favour the cost-effectiveness of
RST over MMT at current drug prices. In con-
trast, personnel costs constituted only a small
proportion of total costs, thus savings made by
factors such as increased worker productivity are
likely to have little effect on the overall cost of
the programme.
Since some of the procedures for measuring costs
and outcomes involve estimates or assumptions,
it is necessary to assess whether variations in
these assumptions change the conclusions. For
reasons of clarity, the only sensitivity analysis
undertaken for this paper involved a reduction in
drug costs. Further sensitivity analysis is the sub-
ject of continuing work. Particularly pertinent
will be variations in compliance rates for treat-
ment and screening, and diagnostic sensitivity
and specificity. The itemized framework that has
been developed permits variations in unit costs
and economic, demographic and epidemiological
parameters to be considered in a manner that
allows application to other endemic areas.
Whatever control measure is chosen it is impor-
tant that changes in infection and morbidity as a
result of intervention are monitored through
time, as a fall in levels of endemicity may have a
dramatic effect on the cost-effectiveness of the
chosen approach. The analysis presented here
strongly suggests that the use of existing primary
health care services can be an affordable and
cost-effective approach to schistosomiasis con-
trol. However, the possible value of special
vertical-type programmes in some instances
should not be ignored. For example, mass treat-
ment by a mobile team may be highly cost-
effective in areas of high endemicity and high
focality. Accordingly, further analyses are being
undertaken on a combination of approaches
within this District - for instance, mass treatment
by a mobile team in areas of high endemicity and
high focality, and PTT in areas of lower
endemicity.
This, however, implies that highly endemic
villages can be identified relatively cheaply. The
availability of rapid, inexpensive methods of
identifying high-risk areas for S. haematobium
through questionnaires (Lengeler et al. 1991a,b;
1992) is a possible solution and a two-step
strategy for the attack phase of a control pro-
gramme may prove feasible. In the first step the
questionnaire could be used to identify high and
low risk areas, and the second step would involve
implementing the most feasible and cost-
effective option for control in each type of area.
This is the subject of ongoing research.
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